LEGAL ALERT: FDA sends warns 15 companies for allegedly selling CBD products that violate the FD&C Act (FDA)

FDA sent warning letters to 15 companies for allegedly selling products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). In a press release, the FDA stated that based on the lack of scientific information supporting the safety of CBD in food, it cannot conclude that CBD is … Continue reading LEGAL ALERT: FDA sends warns 15 companies for allegedly selling CBD products that violate the FD&C Act (FDA)

ADVISORY: American Botanical Council Submits Comments to FDA Suggesting Rescheduling of Cannabis

ABC ADVISORY American Botanical Council Submits Comments to FDA Suggesting Rescheduling of Cannabis ABC highlights clinical research supporting therapeutic benefits, noting that current Schedule I drug status significantly impedes research efforts on cannabis, cannabis preparations, and its compounds AUSTIN, Texas (April 26, 2018) — The nonprofit American Botanical Council (ABC) recently submitted comments to the US Food … Continue reading ADVISORY: American Botanical Council Submits Comments to FDA Suggesting Rescheduling of Cannabis

ABC Requests FDA to Continue to Revise the New Dietary Ingredient Draft Guidance

Nonprofit science organization says FDA’s NDI draft guidance exceeds scope of current law and intent of Congress On December 12, 2016, the nonprofit American Botanical Council (ABC) filed comments in response to the US Food and Drug Administration’s (FDA’s) Notice of Availability of a revised draft guidance for industry titled “Dietary Supplements: New Dietary Ingredient … Continue reading ABC Requests FDA to Continue to Revise the New Dietary Ingredient Draft Guidance